2022
DOI: 10.1186/s12859-022-04670-6
|View full text |Cite
|
Sign up to set email alerts
|

De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet

Abstract: Background With a growing amount of (multi-)omics data being available, the extraction of knowledge from these datasets is still a difficult problem. Classical enrichment-style analyses require predefined pathways or gene sets that are tested for significant deregulation to assess whether the pathway is functionally involved in the biological process under study. De novo identification of these pathways can reduce the bias inherent in predefined pathways or gene sets. At the same time, the defi… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 125 publications
0
0
0
Order By: Relevance
“…Multi-omic integration methods have been developed for diverse applications (Maghsoudi et al ., 2022; Zitnik et al ., 2023), such as embedding single-cell data (Ashuach et al ., 2023; Argelaguet et al ., 2020), clustering cancer samples (Chauvel et al ., 2020; Wang et al ., 2014), and pathway reconstruction (Tuncbag et al ., 2016; Winkler et al ., 2022; Paull et al ., 2013). Multi-omics analyses have been particularly prominent in cancer, with pathway enrichment (Paczkowska et al ., 2020), representation learning (Leng et al ., 2022), supervised prediction of cancer subtypes or patient outcomes (Poirion et al ., 2021; Choi and Chae, 2023), and biologically interpretable neural networks (Wysocka et al ., 2023) as representative areas of study.…”
Section: Discussionmentioning
confidence: 99%
“…Multi-omic integration methods have been developed for diverse applications (Maghsoudi et al ., 2022; Zitnik et al ., 2023), such as embedding single-cell data (Ashuach et al ., 2023; Argelaguet et al ., 2020), clustering cancer samples (Chauvel et al ., 2020; Wang et al ., 2014), and pathway reconstruction (Tuncbag et al ., 2016; Winkler et al ., 2022; Paull et al ., 2013). Multi-omics analyses have been particularly prominent in cancer, with pathway enrichment (Paczkowska et al ., 2020), representation learning (Leng et al ., 2022), supervised prediction of cancer subtypes or patient outcomes (Poirion et al ., 2021; Choi and Chae, 2023), and biologically interpretable neural networks (Wysocka et al ., 2023) as representative areas of study.…”
Section: Discussionmentioning
confidence: 99%